Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

Progress and prospects of Sacubitril/Valsartan: Based on heart failure with preserved ejection fraction

Published:2022-11 Issue: Volume:155 Page:113701
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Jia Ruoyu,Ji Ying,Sun Dong

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference142 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines;Yancy;Circulation,2013

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. Committee of the report on cardiovascular health and diseases in China, report on cardiovascular health and diseases in China 2019: an updated summary;A. The Writing;Chin. Circ. J.,2020

4. Prospective randomized cumulative survival study, effect of carvedilol on survival in severe chronic heart failure;Packer;N. Engl. J. Med.,2001

5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators;Pitt;N. Engl. J. Med.,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction;Reviews in Cardiovascular Medicine;2024-07-23

2. Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center;Medical Science Monitor;2024-06-10

3. The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions;Current Cardiology Reviews;2024-05

4. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction;European Journal of Pharmacology;2023-12

5. Effects of Angiotensin Receptor-Neprilysin Inhibitors Versus Enalapril or Valsartan on Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2023-07-08